US Patent Issued to RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL on Dec. 9 for "Recombinant virus products and methods for inhibiting expression of dystrophia myotonica protein kinase and/or interfering with a trinucleotide repeat expansion in the 3' untranslated region of the DMPK gene" (Ohio Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,402, issued on Dec. 9, was assigned to RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL (Columbus, Ohio).

"Recombinant virus products and methods for inhibiting expression of dystrophia myotonica protein kinase and/or interfering with a trinucleotide repeat expansion in the 3' untranslated region of the DMPK gene" was invented by Nicolas Sebastien Wein (Columbus, Ohio), Scott Quenton Harper (Powell, Ohio) and Kelly Reed Clark (Columbus, Ohio).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to RNA interference-based methods for inhibiting the expression of the dystrophia myotonia protein kinase (DMPK) gene. Recombinant...